Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23277733 | 0.82 | CYP2D6 (0.30) | — | |
| SCHEMBL23745041 | 0.81 | MTNR1A (0.31) | MTNR1AMTNR1B | |
| SCHEMBL21169172 | 0.78 | CYP2D6 (0.32) | — | |
| SCHEMBL23190982 | 0.73 | — | — | |
| SCHEMBL15063824 | 0.73 | DGAT1 (0.33) | — | |
| SCHEMBL23745157 | 0.72 | MTNR1A (0.33) | MTNR1AMTNR1B | |
| SCHEMBL23277761 | 0.72 | ALDH1A1 (0.32) | — | |
| SCHEMBL64420 | 0.71 | CYP2D6 (0.33) | — | |
| SCHEMBL21935476 | 0.70 | DGAT1 (0.31) | — | |
| SCHEMBL15934038 | 0.70 | CYP2D6 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024137742-A1 | COMPOUNDS AND COMPOSITIONS AS FGFR3 DEGRADERS AND USES THEREOF | BLUEPRINT MEDICINES CORPORATION (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2021158707-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. (US) | 2021-08-12 | — | — | WO | disclosed |